about
Androgen inhibition of MAP kinase pathway and Elk-1 activation in proliferating osteoblastsGenetically correlated effects of selective breeding for high and low methamphetamine consumption.Signaling pathways implicated in androgen regulation of endocortical boneAndrogen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severityA new look at the 5alpha-reductase inhibitor finasteride.Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation.Individual differences in hyperlipidemia and vitamin E status in response to chronic alcohol self-administration in cynomolgus monkeysBone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts.Stem cell activation in adults can reverse detrimental changes in body composition to reduce fat and increase lean mass in both sexes.The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches.Sex differences in the effect of finasteride on acute ethanol withdrawal severity in C57BL/6J and DBA/2J mice.Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine).Androgens and bone growth: it's location, location, location.Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton.The Effect of mGluR5 Antagonism During Binge Drinkingon Subsequent Ethanol Intake in C57BL/6J Mice: Sex- and Age-Induced DifferencesSelected line difference in the effects of ethanol dependence and withdrawal on allopregnanolone levels and 5alpha-reductase enzyme activity and expression.Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts.Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function.Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.Osteoblast differentiation influences androgen and estrogen receptor-alpha and -beta expression.Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal.Alteration of kappa-opioid receptor system expression in distinct brain regions of a genetic model of enhanced ethanol withdrawal severity.Alcohol effects on central nervous system gene expression in genetic animal models.Impact of sex: determination of alcohol neuroadaptation and reinforcement.Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals.Identification of neuroendocrine-specific protein as an ethanol-regulated gene with mRNA differential display.Males and females are just different: sexually dimorphic responses to chronic ethanol exposure in hippocampal slice cultures.Androgen receptor overexpression is neuroprotective in experimental stroke.Elevated testosterone in females reveals a robust sex difference in altered androgen levels during chronic alcohol withdrawal.Elevated prodynorphin expression associated with ethanol withdrawal convulsions.
P50
Q28575336-36300C28-D4BF-4127-B759-6C61661BEAD2Q30491913-F9BB0971-F449-44F1-8A3D-3A314438500CQ33664050-DF883FFF-AD44-4828-A2B1-BA48C458EBADQ34387090-744330E4-08DC-4117-80BA-42DFB845CAA4Q34481637-00DF6C08-921C-41D3-A391-EDB1BA776CF3Q34546591-3E8B1FC8-D5ED-4EB8-B95B-F28893506A32Q35036928-458864CA-3444-4A29-BEA7-62658095123AQ35048354-0A90AA42-AF94-4AB6-A75F-B65B957A1F2EQ35196475-0B8D0062-A423-4D4A-8702-0903FBD92D26Q35449237-3056AF84-0E35-4333-AB07-52B779BDDF71Q35648338-30D8EAA8-B486-4F33-BEE3-7516CC9E952CQ35968407-4583AB51-B348-4950-9871-5BD759A1B1FFQ36221359-F900257C-C9AF-4DE9-BA9E-4E492FF1A337Q36268681-FDADFD12-DB34-48C2-A19C-5E6FA2C05966Q36952225-04778953-75E6-451F-8BEE-6B17F768B8A6Q37294421-2D2798AD-F4D3-4184-8E9B-74ECB4303E1FQ37463840-9CB260DF-7B90-45FB-BE63-96F3A92A9DCAQ38302656-A5829167-AEC0-4FC4-9C49-EF751C752FBBQ40248681-A82CBE7E-84FD-4417-BC35-AC27066911D3Q40858557-8B4CAE4F-0E4D-4075-A7B0-2C43CD09C908Q42168008-06A6A133-F030-42E7-B972-C50E57EE604BQ44244452-82B9D712-FF1F-4674-8CA8-23976C0EF882Q44331750-2E564025-0505-4D40-AFDA-4EB3BEAD7D85Q44348871-15248B18-8755-432C-BA3A-8E165E4D92AAQ45267626-D4D5B986-B523-4D51-9339-E020446FF034Q46464568-E45153A4-54CA-4D17-8250-D5B44A830611Q47637555-B17C6599-AA2E-4CD6-8D9C-B44244D331C7Q48310559-CA3EB3F3-A8FB-4EA7-99B3-7366E56AE0D7Q48454455-E99DB706-E43B-41FE-A776-3F06399786C9Q48926138-FF47AC6E-41AC-4CA8-BFC5-9CB37FEE9041Q49040389-A6C00E6B-17C5-40CE-859D-DA8F5918F5C9Q54046629-8C1CA0DD-B292-4628-8F78-5BA9AC7D73FD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kristine M Wiren
@es
Kristine M Wiren
@nl
Kristine M Wiren
@sl
Kristine M. Wiren
@en
type
label
Kristine M Wiren
@es
Kristine M Wiren
@nl
Kristine M Wiren
@sl
Kristine M. Wiren
@en
prefLabel
Kristine M Wiren
@es
Kristine M Wiren
@nl
Kristine M Wiren
@sl
Kristine M. Wiren
@en
P106
P1153
7004224174
P21
P31
P496
0000-0002-6159-4450
P569
2000-01-01T00:00:00Z